The immunological outcome of dendritic cell (DC) treatment with different biomaterials was assessed to demonstrate the range of DC phenotypes induced by biomaterials commonly used in combination products. Immature DCs (iDCs) were derived from human peripheral blood monocytes, and treated with different biomaterial films of alginate, agarose, chitosan, hyaluronic acid (HA), or 75:25 poly(lactic-coglycolic acid) (PLGA) and a comprehensive battery of phenotypic functional outcomes was assessed. Different levels of functional changes in DC phenotype were observed depending on the type of biomaterial films used to treat the DCs. Treatment of DCs with PLGA or chitosan films supported DC maturation, with higher levels of DC allostimulatory capacity, pro-inflammatory cytokine release, and expression of CD80, CD86, CD83, HLA-DQ and CD44 compared with iDCs, and lower endocytic ability compared with iDCs. Alginate film induced pro-inflammatory cytokine release from DCs at levels higher than from iDCs. Dendritic cells treated with HA film expressed lower levels of CD40, CD80, CD86 and HLA-DR compared with iDCs. They also exhibited lower endocytic ability and CD44 expression than iDCs, possibly due to an insolubilized (cross-linked) form of high molecular weight HA. Interestingly, treatment of DCs with agarose film maintained the DC functional phenotype at levels similar to iDCs except for CD44 expression, which was lower than that of iDCs. Taken together, these results can provide selection criteria for biomaterials to be used in immunomodulating applications and can inform potential outcomes of biomaterials within combination products on associated immune responses as desired by the application.
Introduction
In tissue engineering applications immune responses should be minimized, whereas vaccine strategies aim to enhance the protective immune response. Adjuvants enhance an immune response by interacting with antigen-presenting cells (APCs) such as dendritic cells (DCs) during the innate immune response which, upon maturation, bridge the innate and adaptive immune response by stimulating T lymphocytes. Hence, the adjuvant effect of biomaterials can be determined by assessing their effect on the maturation of DCs.
Biomaterial properties such as hydrophobicity/hydrophilicity direct protein adsorption on the biomaterial and complement activation of the surface functionalized with these ligands, which are recognized by pattern recognition receptors (PRRs) on DCs and function in a synergistic manner in controlling the immune response to associated antigens In this study the immunobiological functional response of DCs to a variety of biomaterials commonly used in combination products, such as vaccine delivery vehicles or tissue engineered scaffolds, was assessed. The biomaterials used in this study included PLGA as a synthetic polymer and chitosan, alginate, hyaluronic acid (HA), and agarose as natural polysaccharide polymers [13] [14] [15] . These biomaterials have been used as scaffolds and cell carriers
